http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200106094-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2015-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15e1f93f8225a28f01368cfd5dd22240
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d6ddbc6a01b364b72bd01042fb5768b
publicationDate 2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200106094-A
titleOfInvention Administration of tasimelteon under fasted conditions
abstract An embodiment of the present invention provides a method of administering tasimelteon to a patient, comprising orally administering an effective amount of tasimelteon under fasting conditions. Fasting conditions include administration of tasimeltheone without food, no food for at least 1/2 hour before administration, no food for at least 1 hour before administration, no food for at least 1 to 1/2 hour before administration, or No food for at least 2 hours, no food for at least 2 to 1/2 hours prior to administration, or no food for at least 3 hours prior to administration. According to these embodiments, tasimeltheone may be administered at a dose of, for example, 20 mg/d. Tasimeltheone can be administered, for example, to a patient being treated for circadian rhythm disorders or for sleep disorders, including, for example, non-24 hour disorders.
priorityDate 2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013197076-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412510160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10220503

Total number of triples: 21.